Tempest Therapeutics, Inc. (OVAS) [Rocket]

News + Filings

All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Tempest Therapeutics, Inc. (OVAS)

Create: Alert

All | News | Filings

Date Filed	Type	Description
02/14/2023	SC 13G	EcoR1 Capital, LLC reports a 10% stake in Tempest Therapeutics Inc.
02/17/2022	SC 13G	LAV Regulus Ltd reports a 2.2% stake in Tempest Therapeutics, Inc.
02/10/2022	SC 13G	Versant Venture Capital VI, L.P. reports a 17.1% stake in Tempest Therapeutics, Inc.
01/03/2022	SC 13G	Rock Springs Capital Management LP reports a 11.5% stake in Tempest Therapeutics, Inc.
07/08/2021	SC 13G	Rock Springs Capital Management LP reports a 9.7% stake in Tempest Therapeutics, Inc.
07/06/2021	SC 13G	FMR LLC reports a 9.8% stake in TEMPEST THERAPEUTICS INC
04/07/2021	SC 13G	Ikarian Capital, LLC reports a 7.1% stake in Millendo Therapeutics, Inc.
03/15/2021	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/17/2018	SC 13G	ROCHE FINANCE LTD reports a 5.9% stake in Millendo Therapeutics, Inc.
12/17/2018	SC 13G	Frazier Healthcare VI, L.P. reports a 10.8% stake in Millendo Therapeutics, Inc.
12/17/2018	SC 13G	SHAM Innovation Sante SAS reports a 5.3% stake in Millendo Therapeutics, Inc.
12/17/2018	SC 13G	GREAT POINT PARTNERS LLC reports a 10% stake in Millendo Therapeutics, Inc.
10/26/2018	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/29/2018	SC 13G	HIRSCHMAN ORIN reports a 6.2% stake in Ovascience, Inc.
03/28/2018	SC 13G	BML Investment Partners, L.P. reports a 6.4% stake in OvaScience, Inc.
03/31/2017	SC 13G	EcoR1 Capital, LLC reports a 9.9% stake in OvaScience, Inc.
01/30/2017	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals
02/16/2016	SC 13G	OvaScience, Inc. reports a 7.7% stake in OvaScience, Inc.
02/12/2013	SC 13G	OvaScience, Inc. reports a 3.4% stake in OvaScience, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy